PapersFlow Research Brief
Pharmaceutical studies and practices
Research Guide
What is Pharmaceutical studies and practices?
Pharmaceutical studies and practices is the interdisciplinary body of research and professional activity that develops, evaluates, regulates, and uses medicines through laboratory standards, pharmacology, clinical testing, safe prescribing, pharmacokinetics, and patient-centered medication management.
Pharmaceutical studies and practices spans core scientific foundations (e.g., receptor antagonism quantification in "SOME QUANTITATIVE USES OF DRUG ANTAGONISTS" (1959) and drug disposition modeling in "Pharmacokinetics" (1982)) and applied clinical guidance (e.g., "Harrison's Principles of Internal Medicine." (1988) and "The Pharmacological Basis of Therapeutics" (1976)). Medication-use quality and safety are central themes, including adherence (Osterberg and Blaschke (2005) in "Adherence to Medication"; De Geest and Sabaté (2003) in "Adherence to Long-Term Therapies: Evidence for Action") and adverse drug reactions (Lazarou et al. (1998) in "Incidence of Adverse Drug Reactions in Hospitalized Patients"). The provided corpus metadata lists 116,976 works for this topic, with a 5-year growth rate reported as N/A.
Research Sub-Topics
Medication Adherence Interventions
Researchers evaluate behavioral, technological, and educational strategies to improve patient adherence in chronic diseases like hypertension and diabetes. Meta-analyses assess long-term outcomes and cost-effectiveness.
Adverse Drug Reactions Epidemiology
Studies quantify incidence, preventability, and risk factors of ADRs in hospitalized patients using prospective surveillance. Focus includes pharmacovigilance systems and high-risk drug classes.
Pharmacokinetic Modeling
This subfield develops compartmental and physiologically-based PK models to predict drug absorption, distribution, metabolism, and excretion. Applications span dosing optimization in pediatrics and special populations.
Drug Antagonist Quantification
Researchers apply Schild analysis and operational models to measure affinity and efficacy of competitive antagonists. Studies characterize receptor interactions in GPCR pharmacology.
Clinical Laboratory Standards
Efforts standardize antimicrobial susceptibility testing and therapeutic drug monitoring via CLSI/NCCLS guidelines. Research validates methods for accuracy across labs.
Why It Matters
Pharmaceutical studies and practices directly affects patient outcomes by determining whether medicines are selected appropriately, used safely, and taken as intended. Adherence is a concrete example: Osterberg and Blaschke (2005) in "Adherence to Medication" argued that “the full benefit of many effective medications will be achieved only if patients adhere to prescribed treatment regimens,” framing adherence as a practical determinant of effectiveness rather than a purely behavioral label. Drug safety is another high-impact application area: Lazarou, Pomeranz, and Corey (1998) in "Incidence of Adverse Drug Reactions in Hospitalized Patients" concluded that the incidence of serious and fatal adverse drug reactions (ADRs) in US hospitals was “extremely high,” positioning ADR monitoring and prevention as a core clinical and health-system priority. Standardization underpins both efficacy and safety; Bruck (1980) in "National Committee for Clinical Laboratory Standards" described the National Committee for Clinical Laboratory Standards (NCCLS) as a valuable organization with structured membership, highlighting how laboratory standards support reliable diagnostics and therapeutic monitoring that inform prescribing decisions. At the methodological level, "SOME QUANTITATIVE USES OF DRUG ANTAGONISTS" (1959) provided quantitative receptor-based tools (pAx) for comparing antagonists and identifying shared receptor mechanisms, while "Pharmacokinetics" (1982) established concepts used to design dosing regimens and interpret concentration–time behavior in clinical settings.
Reading Guide
Where to Start
Start with Osterberg and Blaschke’s "Adherence to Medication" (2005) because it frames a widely encountered, practice-facing problem (medication-taking behavior) in clear clinical terms and motivates why pharmaceutical practice must address implementation barriers, not only drug choice.
Key Papers Explained
Mechanistic and measurement foundations begin with Arunlakshana and Schild’s "SOME QUANTITATIVE USES OF DRUG ANTAGONISTS" (1959), which provides a quantitative receptor-competition framework (pAx) for comparing antagonists. Dosing and concentration–time reasoning is then systematized in Gibaldi and Perrier’s "Pharmacokinetics" (1982), which supplies concepts used when translating pharmacology into practical regimens. These scientific foundations connect to broad therapeutic decision-making in "The Pharmacological Basis of Therapeutics" (1976) and "Harrison's Principles of Internal Medicine." (1988), which situate drug mechanisms and dosing within disease management. Practice quality and outcomes are emphasized by Lazarou et al.’s "Incidence of Adverse Drug Reactions in Hospitalized Patients" (1998) and by adherence-focused syntheses in "Adherence to Long-Term Therapies: Evidence for Action" (2003) and "Adherence to Medication" (2005), which together highlight that safety and effectiveness depend on both system performance and patient experience.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Advanced work in pharmaceutical studies and practices, as reflected by the most-cited core literature provided, centers on integrating (i) standardized measurement and laboratory procedures ("National Committee for Clinical Laboratory Standards" (1980)), (ii) quantitative pharmacology and pharmacokinetics ("SOME QUANTITATIVE USES OF DRUG ANTAGONISTS" (1959); "Pharmacokinetics" (1982)), and (iii) real-world medication-use outcomes such as adherence and ADRs ("Adherence to Medication" (2005); "Incidence of Adverse Drug Reactions in Hospitalized Patients" (1998)). A practical frontier is building medication-use systems that simultaneously optimize regimen design, detect preventable harms, and support long-term use, aligning the safety signal from Lazarou et al. (1998) with the implementation focus from Osterberg and Blaschke (2005).
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | National Committee for Clinical Laboratory Standards | 1980 | PEDIATRICS | 14.8K | ✕ |
| 2 | Harrison's Principles of Internal Medicine. | 1988 | Annals of Internal Med... | 12.6K | ✕ |
| 3 | Arzneimittelforschung | 2005 | Bundesgesundheitsblatt... | 9.4K | ✕ |
| 4 | ECDEU Assessment Manual for Psychopharmacology | 1976 | Internet Archive (Inte... | 8.8K | ✕ |
| 5 | The Pharmacological Basis of Therapeutics | 1976 | American Journal of He... | 8.2K | ✕ |
| 6 | Adherence to Medication | 2005 | New England Journal of... | 7.8K | ✕ |
| 7 | Adherence to Long-Term Therapies: Evidence for Action | 2003 | European Journal of Ca... | 6.3K | ✕ |
| 8 | Incidence of Adverse Drug Reactions in Hospitalized Patients | 1998 | JAMA | 4.8K | ✕ |
| 9 | Pharmacokinetics | 1982 | — | 4.1K | ✕ |
| 10 | SOME QUANTITATIVE USES OF DRUG ANTAGONISTS | 1959 | British Journal of Pha... | 4.0K | ✓ |
In the News
Soley Therapeutics Announces Breakthrough Research ...
SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )--Soley Therapeutics: $200 Million Series C Financing to Propel Lead Oncology Programs into the Clinic and Scale Its Cell Stress Sensing Platform... S...
Future of Pharma: Breakthroughs at Scale
**By 2035, the pharmaceutical industry is poised to play a more expansive and transformative role in healthcare. Breakthroughs in science enable pharmaceutical companies to treat, and even cure, di...
NIH to prioritize human-based research technologies
The National Institutes of Health (NIH) is adopting a new initiative to expand innovative, human-based science while reducing animal use in research. Developing and using cutting-edge alternative n...
Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
The purpose of this funding opportunity is to support research to advance the development of safe and effective medications for the treatment of Substance Use Disorders (SUD). It includes preclinic...
2026 Funding Decisions Notifications - CIHR
|Funding Opportunity|Competition|Funding Decision| Project Grant: Fall 2025 and Spring 2026 |202509PJT| View |
Code & Tools
The R projects in this repository designed for the programmers in clinical research who are familiar with programming concepts and who might have p...
clintrials is a library of clinical trial designs and methods in Python. This library is intended to facilitate research.
valtools helps automate the validation of R packages used in clinical research and drug development: It provides useful templates and helper functi...
An application of this library to build an external control arm in a pharmaceutical setting is presented here . ## Features
- **rpact** is a comprehensive validated 1 R package for clinical research which - enables the design and analysis of confirmatory adaptive group ...
Recent Preprints
Pharmacy Practice
### An overview on pharmacist-managed prescription renewal Victoria Bell, Marta Portulez Gigante, Ana Rita Rodrigues Abstract 488 \| PDF Downloads 264 Page 1-9 PDF ## Original Research ###...
international journal of pharmaceutical sciences and research
International Journal of Pharmaceutical Sciences and Research (IJPSR) is an publication of Society of Pharmaceutical Sciences & Research. It is an open access online and print International Journal...
Integrated Pharmacy Research and Practice | Journal
_Integrated Pharmacy Research and Practice_ is an international, peer-reviewed, open access, online journal publishing research in all areas of academic and professional pharmacy practice.
International Journal of Pharmaceutical Sciences and Drug ...
- Pharmaceutical Technology - Pharmaceutics - Biopharmaceutics - Pharmacokinetics - Pharmaceutical/Medicinal Chemistry - Computational Chemistry - Molecular Drug Design - Pharmacognosy - Phytochemi...
Clinical Pharmacy and Pharmacology
Home Publications Multimedia For Authors # Clinical Pharmacy and Pharmacology Explore the latest in clinical pharmacy and pharmacology, including topics in drug safety, development, pharmacoge...
Latest Developments
Recent developments in pharmaceutical studies and practices as of February 2026 highlight significant advances in drug development, including the use of New Approach Methodologies (NAMs) and regulatory changes aimed at speeding up and improving safety (drugtargetreview.com). The industry is also focusing on scientific breakthroughs such as cell-free biomanufacturing systems (cas.org), and there is ongoing research into innovative therapies like oral semaglutide for high-risk type 2 diabetes (nejm.org). Additionally, the industry faces external challenges related to regulatory and geopolitical volatility, while technological innovations, including AI, continue to shape research and development practices (zs.com).
Sources
Frequently Asked Questions
What is meant by pharmaceutical studies and practices in academic research?
Pharmaceutical studies and practices is the combined study of how medicines are discovered and characterized, how their effects are measured and modeled, and how they are used in real clinical workflows. The provided literature anchors this from mechanistic quantification ("SOME QUANTITATIVE USES OF DRUG ANTAGONISTS" (1959)) through dosing science ("Pharmacokinetics" (1982)) to clinical guidance ("Harrison's Principles of Internal Medicine." (1988)).
How do researchers quantify and compare drug antagonists in pharmacology?
Arunlakshana and Schild (1959) in "SOME QUANTITATIVE USES OF DRUG ANTAGONISTS" discussed applications of pAx measurements under a mass-law competition hypothesis, using pAx to identify agonists acting at the same receptors and to compare receptor antagonists. This provides a quantitative framework for mechanism-based comparison rather than relying only on qualitative pharmacologic descriptions.
How is pharmacokinetics used to guide dosing and therapeutic decisions?
"Pharmacokinetics" (1982) formalized pharmacokinetic concepts used to interpret drug concentration–time relationships and supports dose selection and adjustment in clinical practice. In applied medicine, such dosing logic is integrated into broader clinical decision-making described in "Harrison's Principles of Internal Medicine." (1988) and drug-therapy references such as "The Pharmacological Basis of Therapeutics" (1976).
Why is medication adherence treated as a core problem in pharmaceutical practice?
Osterberg and Blaschke (2005) in "Adherence to Medication" stated that the full benefit of many effective medications is achieved only when patients adhere to prescribed regimens and cautioned that labeling patients as “noncompliant” can be stigmatizing. De Geest and Sabaté (2003) in "Adherence to Long-Term Therapies: Evidence for Action" further positioned adherence as a long-term therapy issue requiring evidence-informed action rather than a one-time counseling message.
Which evidence highlights the clinical importance of adverse drug reactions in hospitals?
Lazarou, Pomeranz, and Corey (1998) in "Incidence of Adverse Drug Reactions in Hospitalized Patients" reported that serious and fatal ADR incidence in US hospitals was extremely high, while also noting heterogeneity among studies and potential small sample biases. The paper’s conclusion supports prioritizing ADR detection, prevention, and medication safety systems as central components of pharmaceutical practice.
Which foundational references are commonly used to connect pharmacology to bedside practice?
"The Pharmacological Basis of Therapeutics" (1976) is a core pharmacology reference linking drug mechanisms to therapeutic use, and "Harrison's Principles of Internal Medicine." (1988) is a broad clinical medicine reference integrating pharmacotherapy across organ systems. For psychopharmacology assessment methods, Guy (1976) compiled "ECDEU Assessment Manual for Psychopharmacology," which is frequently cited in contexts that require standardized evaluation approaches.
Open Research Questions
- ? How can adherence interventions be designed to improve real-world medication-taking without stigmatizing patients, consistent with the concerns raised in "Adherence to Medication" (2005)?
- ? Which hospital processes most effectively reduce the burden of serious and fatal ADRs highlighted as “extremely high” in "Incidence of Adverse Drug Reactions in Hospitalized Patients" (1998)?
- ? How can receptor-based quantitative measures such as pAx be integrated with clinical pharmacokinetic reasoning to improve drug selection and dose optimization across patient subgroups?
- ? What minimal laboratory standardization elements (as implied by the role of NCCLS in "National Committee for Clinical Laboratory Standards" (1980)) most strongly improve the reliability of therapeutic monitoring and downstream prescribing decisions?
Recent Trends
Within the provided evidence, the most visible shift in emphasis is from primarily mechanistic quantification ("SOME QUANTITATIVE USES OF DRUG ANTAGONISTS" ) and foundational pharmacology references ("The Pharmacological Basis of Therapeutics" (1976)) toward medication-use outcomes at scale, especially adherence (De Geest and Sabaté (2003) in "Adherence to Long-Term Therapies: Evidence for Action"; Osterberg and Blaschke (2005) in "Adherence to Medication") and patient safety signals (Lazarou et al. (1998) in "Incidence of Adverse Drug Reactions in Hospitalized Patients").
1959The topic-level metadata indicates a large research footprint (116,976 works) while reporting the 5-year growth rate as N/A, so trend direction cannot be quantified from the provided data.
Research Pharmaceutical studies and practices with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching Pharmaceutical studies and practices with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.